Suicide and Self-harmNCT01118156
Suicide Classification System
An observational study of Suicide and Self-harm, run by VA Eastern Colorado Health Care System at 2 sites in United States.
Trial summary
The purpose of this study is to evaluate whether a new standardized language for categorizing suicidal and self-injury related thoughts and behaviors can be readily adopted for use by mental health clinicians. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Suicide and Self-harm
- What is being tested?
- Education
- How many people
- 74 participants
- Where
- 2 sitesUnited States
- Study dates
- Oct 2009to Sep 2010
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Mental Health professionals at the Denver and Grand Junction VA Medical Centers
Who may be able to join
- Suicide Prevention Coordinator team members at Denver or Grand Junction VA Medical Center
- Mental Health leadership at Denver or Grand Junction VA Medical Center
- Mental Health professionals at Denver or Grand Junction VA Medical Center
Who cannot join
- Failure to sign appropriate informed consent
- MIRECC staff members
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Denver VA Medical Center
Denver, Colorado, 80220
Grand Junction VA Medical Center
Grand Junction, Colorado, 81501
About this study
The purpose of this study is to evaluate whether a new standardized language for categorizing suicidal and self-injury related thoughts and behaviors can be readily adopted for use by mental health clinicians. Efforts also include developing a measure that can be used to help clinicians identify appropriate terms (e.g., behaviors) for specific patients.
Read the detailed description
In recent years, suicide prevention has received increased focus within the VA. This is in part related to concerns regarding the mental health and associated suicide risk of Operation Enduring Freedom/Operation Iraqi Freedom military personnel, and a recent study highlighting the increased risk of death by suicide for members of the veteran population. Suicide prevention initiatives could be greatly enhanced if a clinically feasible uniform language regarding suicidality and self-injury was readily available and adopted throughout the VA system. With this goal in mind, the Self-Directed Violence Classification System (SDVCS) and Clinical Tool were developed based upon the Centers for Disease Control and Prevention (CDC) nomenclature and VA VISN-19 MIRECC's work in this area. The purpose of this study is to evaluate whether a new standardized language for categorizing suicidal and self-injury related thoughts and behaviors can be readily adopted for use by mental health clinicians. Efforts also include developing a measure that can be used to help clinicians identify appropriate terms (e.g., behaviors) for specific patients.
- Conditions
- Suicide and Self-harm
- Being tested
- Education
- Keywords
- Suicide Nomenclature
- Medical subject headings
- Suicide, Self-Injurious Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EducationOther
Also called Nomenclature Training
75-minute training teaching utilization of new standardized suicide nomenclature
| Study group | Role | What they receive |
|---|---|---|
| Mental Health Clinicians | MH Clinicians at the Denver and Grand Junction VA Medical Centers Receives: Other: Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of clinicians utilizing nomenclature
Clinician chart notes will be reviewed to determine use of standardized nomenclature. Among those clinicians utilizing the nomenclature, accurate use will also be assessed.
Measured: 6 months
Secondary outcomes (1)
Analysis of qualitative focus group data
Qualitative evaluation of organizational- and provider-level factors associated with implementation
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 May 2010 (estimated)
- Study startOct 2009
- Primary completionSep 2010
- Study completionSep 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Suicide and Self-harmStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 74 participants (actual)
Sponsor and investigators
- Lead sponsor
- VA Eastern Colorado Health Care System
- Sponsor type
- US federal agency
- Investigators
- Lisa Brenner, PhD, Principal investigator, VA ECHCS VISN 19 MIRECC
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01118156
- Sponsor's protocol ID
- 09-0641
- Status last verified
- May 2011
- First submitted
- 4 May 2010
- Last updated
- 3 May 2011
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 3 May 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Suicide Classification System
- ClinicalTrials.gov ID
- NCT01118156
- Acronym / sponsor ID
- 09-0641
- Conditions
- Suicide and Self-harm
- Keywords
- Suicide Nomenclature
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 74 participants (actual)
- Lead sponsor
- VA Eastern Colorado Health Care SystemUS federal agency
- Study start
- Oct 2009
- Primary completion
- Sep 2010 (actual)
- Study completion
- Sep 2010 (actual)
- First posted
- 6 May 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate whether a new standardized language for categorizing suicidal and self-injury related thoughts and behaviors can be readily adopted for use by mental health clinicians. Efforts also include developing a measure that can be used to help clinicians identify appropriate terms (e.g., behaviors) for specific patients.
Detailed description
In recent years, suicide prevention has received increased focus within the VA. This is in part related to concerns regarding the mental health and associated suicide risk of Operation Enduring Freedom/Operation Iraqi Freedom military personnel, and a recent study highlighting the increased risk of death by suicide for members of the veteran population. Suicide prevention initiatives could be greatly enhanced if a clinically feasible uniform language regarding suicidality and self-injury was readily available and adopted throughout the VA system. With this goal in mind, the Self-Directed Violence Classification System (SDVCS) and Clinical Tool were developed based upon the Centers for Disease Control and Prevention (CDC) nomenclature and VA VISN-19 MIRECC's work in this area. The purpose of this study is to evaluate whether a new standardized language for categorizing suicidal and self-injury related thoughts and behaviors can be readily adopted for use by mental health clinicians. Efforts also include developing a measure that can be used to help clinicians identify appropriate terms (e.g., behaviors) for specific patients.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Mental Health Clinicians | – | Other: EducationMH Clinicians at the Denver and Grand Junction VA Medical Centers |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Mental Health professionals at the Denver and Grand Junction VA Medical Centers
Key inclusion criteria (3 listed)
- Suicide Prevention Coordinator team members at Denver or Grand Junction VA Medical Center
- Mental Health leadership at Denver or Grand Junction VA Medical Center
- Mental Health professionals at Denver or Grand Junction VA Medical Center
Key exclusion criteria (2 listed)
- Failure to sign appropriate informed consent
- MIRECC staff members
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EducationAlso: Nomenclature Training75-minute training teaching utilization of new standardized suicide nomenclature | Other | Mental Health Clinicians |
Primary outcome
Proportion of clinicians utilizing nomenclature
Time frame: 6 months
Clinician chart notes will be reviewed to determine use of standardized nomenclature. Among those clinicians utilizing the nomenclature, accurate use will also be assessed.
1 secondary outcome
Analysis of qualitative focus group data
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 May 2011.
- brief descriptions of current research at the VISN 19 MIRECCLink provided by the sponsor.
Related trials for Suicide and Self-harm
Recruiting
Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
Depression and Suicide
Recruiting
Suicide Preventive Psychosocial Treatment for Youths
Suicide Attempt, Suicidal and Self-injurious Behavior
Not yet recruitingPhase 2
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay
Suicidal Ideation, Suicidal Behavior
Recruiting
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis
Clinical High Risk for Psychosis (CHR), Suicidal Ideation
Enrolling by invitationObservational study
Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study
PTSD, Suicidal Thoughts and Behaviors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lisa Brenner, PhD principal investigator
VA ECHCS VISN 19 MIRECC
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Suicide and Self-harm, run by VA Eastern Colorado Health Care System at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 May 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of clinicians utilizing nomenclature (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2011.